These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16922650)

  • 21. The role of hyphenated chromatography-mass spectrometry techniques in exploratory drug metabolism and pharmacokinetics.
    Hsieh Y; Korfmacher W
    Curr Pharm Des; 2009; 15(19):2251-61. PubMed ID: 19601826
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accelerator mass spectrometry-enabled studies: current status and future prospects.
    Arjomand A
    Bioanalysis; 2010 Mar; 2(3):519-41. PubMed ID: 20440378
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In Silico Absorption, Distribution, Metabolism, Excretion, and Pharmacokinetics (ADME-PK): Utility and Best Practices. An Industry Perspective from the International Consortium for Innovation through Quality in Pharmaceutical Development.
    Lombardo F; Desai PV; Arimoto R; Desino KE; Fischer H; Keefer CE; Petersson C; Winiwarter S; Broccatelli F
    J Med Chem; 2017 Nov; 60(22):9097-9113. PubMed ID: 28609624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 25. European Bioanalysis Forum recommendation: scientific validation of quantification by accelerator mass spectrometry.
    Higton D; Young G; Timmerman P; Abbott R; Knutsson M; Svensson LD
    Bioanalysis; 2012 Nov; 4(22):2669-79. PubMed ID: 23210650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ADME-Space: a new tool for medicinal chemists to explore ADME properties.
    Bocci G; Carosati E; Vayer P; Arrault A; Lozano S; Cruciani G
    Sci Rep; 2017 Jul; 7(1):6359. PubMed ID: 28743970
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In silico prediction of ADME and pharmacokinetics. Report of an expert meeting organised by COST B15.
    Boobis A; Gundert-Remy U; Kremers P; Macheras P; Pelkonen O
    Eur J Pharm Sci; 2002 Dec; 17(4-5):183-93. PubMed ID: 12453607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Accelerator mass spectrometry offers new opportunities for microdosing of peptide and protein pharmaceuticals.
    Salehpour M; Ekblom J; Sabetsky V; Håkansson K; Possnert G
    Rapid Commun Mass Spectrom; 2010 May; 24(10):1481-9. PubMed ID: 20411588
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New frontiers-accelerator mass spectrometry (AMS): Recommendation for best practices and harmonization from Global Bioanalysis Consortium Harmonization Team.
    Young GC; Seymour M; Dueker SR; Timmerman P; Arjomand A; Nozawa K
    AAPS J; 2014 Mar; 16(2):357-9. PubMed ID: 24500278
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of microdosing to predict pharmacokinetics at the therapeutic dose: experience with 5 drugs.
    Lappin G; Kuhnz W; Jochemsen R; Kneer J; Chaudhary A; Oosterhuis B; Drijfhout WJ; Rowland M; Garner RC
    Clin Pharmacol Ther; 2006 Sep; 80(3):203-15. PubMed ID: 16952487
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of cAMS for
    Lozac'h F; Fahrni S; Maria D; Welte C; Bourquin J; Synal HA; Pearson D; Walles M; Camenisch G
    Bioanalysis; 2018 Mar; 10(5):321-339. PubMed ID: 29451392
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human absorption, distribution, metabolism and excretion properties of drug molecules: a plethora of approaches.
    Beaumont C; Young GC; Cavalier T; Young MA
    Br J Clin Pharmacol; 2014 Dec; 78(6):1185-200. PubMed ID: 25041729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry in drug metabolism and pharmacokinetics: Current trends and future perspectives.
    Cuyckens F
    Rapid Commun Mass Spectrom; 2019 Jul; 33 Suppl 3():90-95. PubMed ID: 30019507
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMS method validation for quantitation in pharmacokinetic studies with concomitant extravascular and intravenous administration.
    Lappin G; Seymour M; Young G; Higton D; Hill HM
    Bioanalysis; 2011 Feb; 3(4):393-405. PubMed ID: 21338259
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adding value through accelerator mass spectrometry-enabled first in human studies.
    Seymour MA
    J Labelled Comp Radiopharm; 2016 Dec; 59(14):640-647. PubMed ID: 27444819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human ADME for YH12852 using wavelength scanning cavity ring-down spectroscopy (WS-CRDS) after a low radioactivity dose.
    Kim A; Dueker SR; Dong F; Roffel AF; Lee SW; Lee H
    Bioanalysis; 2020 Jan; 12(2):87-98. PubMed ID: 31928227
    [No Abstract]   [Full Text] [Related]  

  • 37. Smarter candidate selection--utilizing microdosing in exploratory clinical studies.
    Buchan P
    Ernst Schering Res Found Workshop; 2007; (59):7-27. PubMed ID: 17117712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microdosing studies in humans: the role of positron emission tomography.
    Bauer M; Wagner CC; Langer O
    Drugs R D; 2008; 9(2):73-81. PubMed ID: 18298126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Use of nano-electrospray for metabolite identification and quantitative absorption, distribution, metabolism and excretion studies.
    Hop CE
    Curr Drug Metab; 2006 Jun; 7(5):557-63. PubMed ID: 16787163
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microdosing studies using accelerated mass spectrometry as exploratory investigational new drug trials.
    Bae SK; Shon JH
    Arch Pharm Res; 2011 Nov; 34(11):1789-98. PubMed ID: 22139681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.